Dr. Ingrid Vasiliu Feltes has emerged as a prominent voice at the intersection of digital health, bioethics, and artificial intelligence governance. Her career spans academic research, regulatory science, and executive leadership across international health organizations. This article examines her professional journey, key contributions to healthcare technology policy, and the frameworks she has helped shape for responsible innovation in medicine.
Quick Answer: Who Is Dr. Ingrid Vasiliu Feltes?
Dr. Ingrid Vasiliu Feltes is a physician-scientist, bioethicist, and digital health strategist known for her work advancing responsible AI in healthcare, shaping regulatory frameworks for digital medical products, and leading ethics and compliance initiatives at major global health institutions. She holds leadership positions spanning the FDA, WHO, and private-sector health technology organizations, with a focus on ensuring that technological innovation in medicine proceeds within robust ethical and regulatory guardrails.
Background: The Intersection of Medicine, Ethics, and Technology
The rapid digitization of healthcare has created an urgent need for professionals who understand clinical practice, ethical theory, and regulatory science in equal measure. Dr. Ingrid Vasiliu Feltes occupies this rare intersection. Her work addresses questions that define modern medicine: how algorithmic decision-making affects patient autonomy, what regulatory pathways should govern software-as-a-medical-device, and how global health equity can be preserved when innovation concentrates in high-resource settings.
Her career reflects a deliberate progression from clinical training to policy architecture. Rather than treating ethics as an afterthought to technological development, she has advocated for “ethics by design” — embedding bioethical principles into the earliest stages of product conception, data collection, and algorithm training. This approach has influenced how regulatory agencies evaluate digital health tools and how multinational organizations develop governance standards for AI in clinical settings.
Education and Early Career Foundations
Dr. Vasiliu Feltes earned her medical degree with a focus on clinical research and bioethics, followed by advanced training in regulatory science and health policy. Her academic foundation includes fellowship work at institutions recognized for leadership in clinical informatics and research ethics. Early in her career, she contributed to clinical trial design and human subjects protection programs, developing expertise in the regulatory requirements that govern medical research across jurisdictions.
This period established her fluency in three languages of modern healthcare: the clinical language of patient care, the technical language of data science and AI, and the normative language of bioethics and law. Colleagues note that this trilingual expertise — clinical, technical, ethical — distinguishes her contributions in forums where specialists often talk past one another.
Leadership Roles in Global Health Organizations
U.S. Food and Drug Administration (FDA)
At the FDA, Dr. Vasiliu Feltes has served in advisory and collaborative capacities related to the Center for Devices and Radiological Health (CDRH) and its Digital Health Center of Excellence. Her input has informed guidance documents on clinical decision support software, artificial intelligence/machine learning (AI/ML)-based software as a medical device (SaMD), and real-world evidence generation for regulatory decision-making.
World Health Organization (WHO)
Her engagement with the WHO includes participation in expert working groups on digital health governance, ethics of AI in health, and the development of global standards for digital health intervention evaluation. These roles position her at the nexus of international policy harmonization — critical when digital health products cross borders instantly but regulatory frameworks remain nationally fragmented.
Private Sector and Advisory Boards
Beyond public institutions, she has held chief ethics and compliance officer roles and served on advisory boards for health technology companies developing AI-driven diagnostics, remote monitoring platforms, and clinical decision support tools. In these positions, she has operationalized ethical frameworks into product development lifecycles, institutional review processes, and post-market surveillance protocols.
Contributions to Digital Health Policy and Standards
Dr. Vasiliu Feltes has been instrumental in shaping several policy domains that define contemporary digital health regulation:
Regulatory Pathways for AI/ML-Enabled Medical Devices
She has advocated for adaptive regulatory frameworks that accommodate the iterative nature of machine learning models — where algorithms evolve through continuous learning — while maintaining safety and effectiveness assurances. Her work supports the FDA’s proposed “Predetermined Change Control Plans” approach, which pre-specifies how and when algorithm updates require regulatory review.
Real-World Evidence (RWE) Integration
Her contributions to RWE frameworks help define how data from electronic health records, wearables, and patient registries can supplement traditional clinical trial evidence for regulatory decisions. This includes methodological standards for data quality, provenance, and bias mitigation.
Interoperability and Data Governance
She has advanced standards for health data interoperability (including FHIR implementation guides) coupled with governance models that protect patient privacy while enabling research and public health surveillance. Her work emphasizes that technical interoperability without ethical interoperability — shared norms for consent, access, and benefit-sharing — is insufficient.
Bioethics and AI Governance Frameworks
Dr. Vasiliu Feltes’s bioethics work centers on translating principled ethics into actionable governance structures. Key focus areas include:
Algorithmic Bias and Health Equity
She has published and spoken extensively on how training data disparities — across race, gender, geography, and socioeconomic status — propagate into clinical AI systems, potentially exacerbating existing health inequities. Her framework for “equity by design” mandates diverse development teams, representative training data, continuous bias auditing, and community engagement throughout the product lifecycle.
Informed Consent in the Age of Continuous Monitoring
Traditional consent models assume discrete interactions. Digital health enables continuous, passive data collection. Dr. Vasiliu Feltes has developed dynamic consent frameworks that give patients granular, ongoing control over data streams from wearables, implantables, and ambient sensors — moving beyond binary “opt-in/opt-out” toward meaningful participatory governance.
Clinical Responsibility and Liability
When an AI system recommends a treatment that harms a patient, responsibility diffuses across developers, regulators, deploying institutions, and clinicians. Her work on distributed accountability models clarifies obligations at each layer, informing emerging legal frameworks and institutional policies for AI adoption in clinical workflows.
Publications and Thought Leadership
Dr. Vasiliu Feltes has authored peer-reviewed articles, white papers, and book chapters spanning:
- Regulatory science for digital health technologies
- Bioethics of AI in clinical decision-making
- Global governance frameworks for health data
- Research ethics in distributed clinical trials
- Equity-centered design of digital health interventions
She is a frequent keynote speaker at conferences including the Digital Medicine Society (DiMe) events, AMIA Annual Symposium, HIMSS Global Conference, and WHO-convened expert consultations. Her presentations bridge technical depth for developer audiences and policy clarity for regulator and legislator audiences — a translation skill that amplifies her influence across stakeholder groups.
Awards, Recognition, and Professional Affiliations
Her contributions have been recognized through fellowships and leadership appointments in:
- American Medical Informatics Association (AMIA)
- International Society for Computational Biology (ISCB)
- Digital Medicine Society (DiMe) expert networks
- IEEE Standards Association working groups on AI ethics
- HL7 and FHIR governance bodies
She has received honors for mentorship, particularly for advancing women and underrepresented groups in health technology leadership — reflecting a personal commitment to diversifying the field that shapes healthcare’s digital future.
Current Focus and Future Directions
Dr. Vasiliu Feltes’s current work addresses three converging challenges:
Generative AI in Clinical Settings
Large language models and foundation models introduce novel risks — hallucination, prompt injection, emergent capabilities — that existing regulatory frameworks did not anticipate. She is developing evaluation rubrics and governance checklists specific to generative AI deployment in clinical documentation, patient communication, and diagnostic reasoning support.
Global Regulatory Convergence
As digital health products scale globally, divergent national regulations create compliance fragmentation and equity gaps. She advocates for mutual recognition agreements, shared evidence standards, and collaborative review pathways among major regulatory authorities (FDA, EMA, Health Canada, PMDA, NMPA, ANVISA, and others).
Workforce Transformation
Clinicians need new competencies to evaluate, adopt, and oversee AI tools. She collaborates with medical education bodies to integrate digital health literacy, algorithmic audit skills, and ethics-of-AI modules into undergraduate, graduate, and continuing medical education curricula.
| Domain | Key Contribution | Impact |
|---|---|---|
| Regulatory Science | Adaptive pathways for AI/ML-enabled SaMD | Informed FDA Digital Health Center of Excellence guidance |
| Global Governance | WHO ethics & governance of AI in health | International standards for digital health evaluation |
| Bioethics | Dynamic consent & equity-by-design frameworks | Operationalized in product lifecycles & institutional policies |
| Standards Development | FHIR, IEEE, HL7 working groups | Interoperability with embedded ethical guardrails |
| Education & Workforce | AI literacy curricula for clinicians | Adopted in medical education reform initiatives |
Dr. Ingrid Vasiliu Feltes represents a generation of leaders who refuse the false choice between innovation and ethics. Her career demonstrates that the most durable healthcare technologies emerge when regulatory rigor, ethical foresight, and clinical wisdom develop together — not in sequence. As generative AI, decentralized clinical trials, and continuous patient-generated data reshape medicine, her frameworks for adaptive governance, equity-centered design, and distributed accountability will remain essential reference points for developers, regulators, clinicians, and patients alike.
For professionals navigating this landscape, her published work and public presentations offer a practical roadmap: start with the patient, embed ethics in architecture, design for regulatory reality, and measure success by whether the most vulnerable populations benefit. That roadmap, more than any single policy or product, constitutes her lasting contribution to digital health.
Frequently Asked Questions
What is Dr. Ingrid Vasiliu Feltes known for?
Dr. Ingrid Vasiliu Feltes is known for her leadership at the intersection of digital health, bioethics, and AI governance. She has shaped regulatory frameworks for AI-enabled medical devices at the FDA, contributed to WHO global standards for digital health ethics, and developed operational ethics-by-design frameworks adopted by health technology companies and international standards bodies.
What are Dr. Ingrid Vasiliu Feltes’s main areas of expertise?
Her expertise spans regulatory science for digital health technologies, bioethics of artificial intelligence in clinical care, global health data governance, research ethics for decentralized trials, and equity-centered design of digital health interventions. She is fluent in clinical, technical, and normative domains of healthcare innovation.
Has Dr. Ingrid Vasiliu Feltes worked with the FDA?
Yes, she has served in advisory and collaborative roles with the FDA’s Center for Devices and Radiological Health (CDRH) and its Digital Health Center of Excellence, contributing to guidance on clinical decision support software, AI/ML-based software as a medical device, and real-world evidence frameworks for regulatory decision-making.
What is her role with the World Health Organization?
Dr. Vasiliu Feltes has participated in WHO expert working groups on digital health governance, ethics of AI in health, and global standards for digital health intervention evaluation. Her work supports international policy harmonization for digital health technologies that cross borders but face fragmented national regulations.
What is the “ethics by design” approach she advocates?
Ethics by design means embedding bioethical principles — autonomy, beneficence, non-maleficence, justice — into the earliest stages of product conception, data collection, algorithm training, and deployment planning, rather than treating ethics as a compliance checkpoint after development is complete.
How does she address algorithmic bias in healthcare AI?
She promotes an “equity by design” framework requiring diverse development teams, representative training data across race, gender, geography, and socioeconomic status, continuous bias auditing throughout the product lifecycle, and meaningful community engagement from design through post-market surveillance.
What is dynamic consent in digital health?
Dynamic consent replaces binary opt-in/opt-out models with granular, ongoing patient control over data streams from wearables, implantables, and ambient sensors. Dr. Vasiliu Feltes has developed frameworks enabling patients to modify permissions in real time as data uses evolve, preserving autonomy in continuous monitoring contexts.
Where can I find Dr. Ingrid Vasiliu Feltes’s publications?
Her peer-reviewed articles, white papers, and book chapters appear in journals covering regulatory science, medical informatics, bioethics, and digital medicine. She also presents regularly at AMIA, DiMe, HIMSS, IEEE, and WHO-convened forums. Searching her name in PubMed, IEEE Xplore, and conference proceedings yields her published work.
